siRNA therapy decreases triglycerides in people with uncommon health condition

.STUDY HIGHLIGHT.19 September 2024.

Plozasiran lessened triglyceride amounts through 80% and also reduced the danger of pancreatitis in individuals along with persistent chylomicronemia, with or without a genetic prognosis.